Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Eur J Med Res ; 27(1): 35, 2022 Mar 03.
Artigo em Inglês | MEDLINE | ID: mdl-35241160

RESUMO

BACKGROUND: Allergic respiratory diseases (ARD) are a highly prevalent health problem affecting infants and children in Yemen. Early infant feeding predisposition to the development of ARD has been a controversial question. The aim of this study is to investigate the association between early feeding before 6 months of age and the development of ARD among children attending Childhood and Maternity Public Hospital (CMPH), Ibb, Yemen Republic. SUBJECTS AND METHODS: The study population included 151 child patients attending the pediatric clinic at CMPH. Upon clinical and laboratory examinations, 72 out of 151 patients had ARD, while the other 79 had diseases other than ARD; all of them were used in risk assessment. Fifteen blood samples from healthy volunteers were used in laboratory investigations as a control. Complete blood count and IgE level were investigated for all participants. Children's parents were requested to give an informed consent and fill questionnaire about demography and history details. RESULTS: Early infant feeding was a significant risk factor for the development of ARD with an odds ratio (OR) of 6.8 and 95% confidence interval (CI) 3.0 to 15.3. Artificial milk particularly was risk factor with an OR of 6.1 and 95% confidence interval 2.7 to 13.5. Artificial milk exhibited more wheezing and asthma attack than others (OR 4.3, 95% CI 1.9 to 9.4 and OR 7.6, 95% CI 3.5 to 16.3, respectively). The risk of wheezing and asthma attack also increase with early feeding generally (OR 3.0, 95% CI 1.3 to 7.2 and OR 4.8, 95% CI 2.2 to 8.1, respectively). The patients had a higher sensitization markers than the control, such as eosinophil count and total serum IgE. The highest levels of IgE ever reported existed among early fed patients with artificial milk. CONCLUSIONS: Early infant feeding, particularly with artificial milk, is a risk factor predisposing infants to the development of allergic respiratory disease presented with more clinical features of wheezing and asthma attack.


Assuntos
Alimentos Infantis , Hipersensibilidade Respiratória/prevenção & controle , População Rural , Adolescente , Estudos de Casos e Controles , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Incidência , Lactente , Recém-Nascido , Masculino , Hipersensibilidade Respiratória/epidemiologia , Fatores de Risco , Iêmen/epidemiologia
3.
J Heart Lung Transplant ; 29(1): 66-71, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19837609

RESUMO

BACKGROUND: Cardiogenic shock refractory to conventional therapy has very high mortality and limited support options. New technology with peripherally inserted CentriMag (Levitronix LLC, Waltham, MA) extracorporal membrane oxygenation (ECMO) may have the potential to significantly improve survival in these critically ill patients. Outcomes of the first 10 patients to receive this device at our institutions are presented. METHODS: Patients were identified by their primary physicians and evaluated by our Mechanical Circulatory Support Team. CentriMag ECMO was initiated at the bedside using sterile percutaneous cannulation of femoral vessels. Patients were admitted to the Heart and Vascular Intensive Care Unit, with care managed by regular nursing staff with special training. RESULTS: The patients (5 men, 5 women) were a mean age of 45 +/- 18 years, had a mean left ventricular ejection fraction of 30%, and a mean lactate level of 9 mmol/liter. All patients met criteria for shock refractory to medical therapy, but the etiology varied. Average duration of ECMO support was 5.8 +/- 4 days. Survival was 60%. There were no major complications directly related to the device and no equipment malfunctions. CONCLUSIONS: The peripherally inserted CentriMag ECMO was easy to insert, functioned without mechanical error, and significantly reduced expected mortality in critically ill patients. Further research will be necessary to develop standardized algorithms and gain more experience, but this new technology has promising potential.


Assuntos
Estado Terminal/terapia , Oxigenação por Membrana Extracorpórea , Choque Cardiogênico/terapia , Adulto , Estado Terminal/mortalidade , Feminino , Humanos , Lactatos/sangue , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Choque Cardiogênico/mortalidade , Choque Cardiogênico/fisiopatologia , Volume Sistólico/fisiologia , Taxa de Sobrevida , Resultado do Tratamento
4.
J Heart Lung Transplant ; 23(11): 1301-3, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15539130

RESUMO

A 39-year-old man with idiopathic dilated cardiomyopathy and New York Heart Association Class III heart failure symptoms underwent orthotopic cardiac transplantation. Post-operatively, he developed an anteroseptal infarct pattern on the electrocardiogram (ECG), without regional wall motion abnormalities according to echocardiography. This pseudo-infarct pattern on ECG resolved within 6 months without coronary intervention or sequelae. It is postulated that these ECG changes were caused by increased left ventricular wall thickness due myocardial wall edema and reperfusion injury after cardiac transplantation.


Assuntos
Eletrocardiografia , Transplante de Coração , Coração/fisiopatologia , Adulto , Diagnóstico Diferencial , Humanos , Masculino , Infarto do Miocárdio/diagnóstico , Complicações Pós-Operatórias/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...